Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKinsey
Julphar
Citi
AstraZeneca
Daiichi Sankyo
US Department of Justice
Mallinckrodt
Accenture

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,290,815

« Back to Dashboard

Summary for Patent: 5,290,815
Title: Treatment of inflammation and allergy
Abstract:The present invention provides a new medical use for the phenethanolamine compound 4-hydroxy-.alpha..sup.1 -[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol and physiologically acceptable salts and solvates thereof in the treatment of inflammation, allergy and allergic reaction.
Inventor(s): Johnson; Malcolm (Orwell, GB2), Whelan; Clifford J. (Buntingford, GB2)
Assignee: Glaxo Group Limited (London, GB2)
Application Number:07/799,001
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,290,815
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,290,815

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,290,815

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8920235Sep 07, 1989
United Kingdom9011940May 29, 1990

International Family Members for US Patent 5,290,815

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2024789 ➤ Try a Free Trial
European Patent Office 0416925 ➤ Try a Free Trial
European Patent Office 1078629 ➤ Try a Free Trial
United Kingdom 8920235 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Healthtrust
Fish and Richardson
McKesson
Accenture
Argus Health
Harvard Business School
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.